Recommended Topic Related To:

Minastrin 24 Fe

"The U.S. Food and Drug Administration today announced that it has approved an amended application submitted by Teva Women's Health, Inc. to market Plan B One-Step (active ingredient levonorgestrel) for use without a prescription by women 15 years"...

Minastrin 24 Fe

INDICATIONS

Minastrin 24 Fe is indicated for use by females of reproductive age to prevent pregnancy [see Clinical Studies].

The efficacy of Minastrin 24 Fe in women with a body mass index (BMI) of more than 35 kg/m² has not been evaluated.

DOSAGE AND ADMINISTRATION

How to Take Minastrin 24 Fe

To achieve maximum contraceptive effectiveness, Minastrin 24 Fe must be taken exactly as directed. Instruct patients to take one capsule by mouth at the same time every day. Capsules must be taken in the order directed on the blister pack. Capsules should not be skipped or taken at intervals exceeding 24 hours. For patient instructions for missed pills, see FDA-approved patient labeling. Minastrin 24 Fe may be administered without regard to meals [see CLINICAL PHARMACOLOGY].

How to Start Minastrin 24 Fe

Instruct the patient to begin taking Minastrin 24 Fe either on the first day of her menstrual period (Day 1 Start) or on the first Sunday after the onset of her menstrual period (Sunday Start).

Day 1 Start

During the first cycle of Minastrin 24 Fe use, instruct the patient to take one yellow Minastrin 24 Fe capsule daily, beginning on Day one (1) of her menstrual cycle (the first day of menstruation is Day one). She should take one yellow Minastrin 24 Fe capsule daily for 24 consecutive days, followed by one maroon capsule daily on days 25 through 28. Minastrin 24 Fe should be taken in the order directed on the package at the same time each day. Instruct the patient to use a non-hormonal contraceptive as back-up during the first 7 days if she starts taking Minastrin 24 Fe on a day other than the first day of her menstrual cycle. The possibility of ovulation and conception prior to initiation of medication should be considered.

Sunday Start

During the first cycle of Minastrin 24 Fe use, instruct the patient to take one yellow Minastrin 24 Fe capsule daily, beginning on the first Sunday after the onset of her menstrual period. She should take one yellow Minastrin 24 Fe capsule daily for 24 consecutive days, followed by one maroon capsule daily on days 25 through 28. Minastrin 24 Fe should be taken in the order directed on the package at the same time each day. Minastrin 24 Fe should not be considered effective as a contraceptive until after the first 7 consecutive days of product administration. Instruct the patient to use a non-hormonal contraceptive as back-up during the first 7 days. The possibility of ovulation and conception prior to initiation of medication should be considered.

The patient should begin her next and all subsequent 28-day regimens of Minastrin 24 Fe on the same day of the week that she began her first regimen, following the same schedule. She should begin taking her yellow capsules on the next day after ingestion of the last maroon capsule, regardless of whether or not a menstrual period has occurred or is still in progress. Anytime a subsequent cycle of Minastrin 24 Fe is started later than the day following administration of the last maroon capsule, the patient should use another method of contraception until she has taken a yellow Minastrin 24 Fe capsule daily for 7 consecutive days.

For postpartum women who do not breastfeed or after a second trimester abortion, start Minastrin 24 Fe no earlier than 4 weeks postpartum due to the increased risk of thromboembolism. If the patient starts on Minastrin 24 Fe postpartum and has not yet had a period, evaluate for possible pregnancy, and instruct her to use an additional method of contraception until she has taken Minastrin 24 Fe for 7 consecutive days.

Minastrin 24 Fe may be initiated immediately after a first-trimester abortion or miscarriage; if the patient starts Minastrin 24 Fe immediately, additional contraceptive measures are not needed.

Switching from another Hormonal Method of Contraception

If the patient is switching from a combination hormonal method such as:

    • Another pill
    • Vaginal ring
    • Patch
  • Instruct her to take the first yellow capsule on the day she would have taken her next COC pill. She should not continue taking the tablet from her previous birth control pack, and should not skip any days between packs. If she does not have a withdrawal bleed, rule out pregnancy before starting Minastrin 24 Fe.
  • If she previously used a vaginal ring or transdermal patch, she should start using Minastrin 24 Fe on the day she would have resumed the previous product.

If the patient is switching from a progestin-only method such as a:

    • Progestin-only pill
    • Implant
    • Intrauterine system
    • Injection
  • She may switch any day from a progestin-only pill; instruct her to take the first yellow capsule on the day she would have taken her next progestin-only pill. She should use a non-hormonal method of contraception for 7 consecutive days.
  • If switching from an implant or injection, start the first yellow capsule on the day her next injection would have been due or on the day of removal of her implant.
  • If switching from an IUD, depending on the timing of removal, back-up contraception may be needed.

Advice in Case of Gastrointestinal Disturbances

If the patient vomits or has diarrhea (within 3 to 4 hours after she takes a yellow capsule), she should follow the instructions in the “What to Do if You Miss Capsules” section [see FDA-approved patient labeling].

HOW SUPPLIED

Dosage Forms And Strengths

Minastrin 24 Fe is available in blister packs.

Each blister pack contains 28 soft gelatin capsules in the following order:

  • 24 oval, transparent, pale yellow, (active) capsules imprinted with “WC” on one side and each containing 1 mg norethindrone acetate and 20 mcg ethinyl estradiol.
  • 4 oval, opaque, maroon, (non-hormonal placebo) capsules imprinted with “WC” on one side and each containing 75 mg ferrous fumarate. The ferrous fumarate capsules do not serve any therapeutic purpose.

Storage And Handling

Minastrin 24 Fe (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) is available in blister cards (dispensers) containing 28 soft gelatin capsules:

Each blister card contains 28 capsules in the following order:

  • 24 oval, transparent, pale yellow, (active) capsules imprinted with “WC” on one side and each containing 1 mg norethindrone acetate and 20 mcg ethinyl estradiol.
  • 4 oval, opaque, maroon, (non-hormonal placebo) capsules imprinted with “WC” on one side and each containing 75 mg ferrous fumarate. The ferrous fumarate capsules do not serve any therapeutic purpose.

Each blister card is packed with a black wallet in a carton (NDC 0430-0539-14).

Cartons of 5 blister cards packed individually in 5 cartons are provided for dispensing (NDC 0430-0539-50).

Storage Conditions

Store at 25° C (77° F); excursions permitted to 15 to 30° C (59 to 86° F) [see USP Controlled Room Temperature]. Protect from light. Store blister card in the wallet provided in the carton when not in use.

Manufactured by: Catalent Pharma Solutions, LLC St. Petersburg, FL 33716 for Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738. Marketed by: Warner Chilcott (US), LLC Rockaway, NJ 07866 1-800-521-8813. Revised: 04/2013

Last reviewed on RxList: 5/6/2013
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.

advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations